324 related articles for article (PubMed ID: 26485106)
1. Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease.
Long MD; Kappelman MD; Martin CF; Chen W; Anton K; Sandler RS
J Clin Gastroenterol; 2016 Feb; 50(2):152-6. PubMed ID: 26485106
[TBL] [Abstract][Full Text] [Related]
2. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study.
Ananthakrishnan AN; Higuchi LM; Huang ES; Khalili H; Richter JM; Fuchs CS; Chan AT
Ann Intern Med; 2012 Mar; 156(5):350-9. PubMed ID: 22393130
[TBL] [Abstract][Full Text] [Related]
3. Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation.
Moninuola OO; Milligan W; Lochhead P; Khalili H
Aliment Pharmacol Ther; 2018 Jun; 47(11):1428-1439. PubMed ID: 29620794
[TBL] [Abstract][Full Text] [Related]
4. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.
Ananthakrishnan AN; Long MD; Martin CF; Sandler RS; Kappelman MD
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):965-71. PubMed ID: 23376797
[TBL] [Abstract][Full Text] [Related]
5. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.
Vavricka SR; Spigaglia SM; Rogler G; Pittet V; Michetti P; Felley C; Mottet C; Braegger CP; Rogler D; Straumann A; Bauerfeind P; Fried M; Schoepfer AM;
Inflamm Bowel Dis; 2012 Mar; 18(3):496-505. PubMed ID: 21509908
[TBL] [Abstract][Full Text] [Related]
6. Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea.
Chung SH; Park SJ; Lee HS; Hong SP; Cheon JH; Kim TI; Kim WH
World J Gastroenterol; 2014 Dec; 20(45):17120-6. PubMed ID: 25493025
[TBL] [Abstract][Full Text] [Related]
7. A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease.
Bonner GF; Fakhri A; Vennamaneni SR
Inflamm Bowel Dis; 2004 Nov; 10(6):751-7. PubMed ID: 15626893
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
[TBL] [Abstract][Full Text] [Related]
9. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
10. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation.
Bortlik M; Duricova D; Machkova N; Hruba V; Lukas M; Mitrova K; Romanko I; Bina V; Malickova K; Kolar M; Lukas M
Scand J Gastroenterol; 2016; 51(2):196-202. PubMed ID: 26329773
[TBL] [Abstract][Full Text] [Related]
12. Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease.
Bonner GF; Walczak M; Kitchen L; Bayona M
Am J Gastroenterol; 2000 Aug; 95(8):1946-8. PubMed ID: 10950040
[TBL] [Abstract][Full Text] [Related]
13. Use of acetaminophen and nonsteroidal anti-inflammatory drugs: a prospective study and the risk of symptomatic diverticular disease in men.
Aldoori WH; Giovannucci EL; Rimm EB; Wing AL; Willett WC
Arch Fam Med; 1998; 7(3):255-60. PubMed ID: 9596460
[TBL] [Abstract][Full Text] [Related]
14. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of adalimumab for the management of inflammatory bowel disease in the clinical setting.
Trinder MW; Lawrance IC
J Gastroenterol Hepatol; 2009 Jul; 24(7):1252-7. PubMed ID: 19220669
[TBL] [Abstract][Full Text] [Related]
16. CD8
Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
[TBL] [Abstract][Full Text] [Related]
17. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
[TBL] [Abstract][Full Text] [Related]
18. Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study.
Narula N; Wong ECL; Pray C; Marshall JK; Rangarajan S; Islam S; Bahonar A; Alhabib KF; Kontsevaya A; Ariffin F; Co HU; Al Sharief W; Szuba A; Wielgosz A; Diaz ML; Yusuf R; Kruger L; Soman B; Li Y; Wang C; Yin L; Mirrakhimov E; Lanas F; Davletov K; Rosengren A; Lopez-Jaramillo P; Khatib R; Oguz A; Iqbal R; Yeates K; Avezum Á; Reinisch W; Moayyedi P; Yusuf S
Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2649-2659.e16. PubMed ID: 36528284
[TBL] [Abstract][Full Text] [Related]
19. Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study.
Carpio D; Barreiro-de Acosta M; Echarri A; Pereira S; Castro J; Ferreiro R; Lorenzo A;
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1030-7. PubMed ID: 26049704
[TBL] [Abstract][Full Text] [Related]
20. Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study.
Sacco R; Romano A; Mazzoni A; Bertini M; Federici G; Metrangolo S; Parisi G; Nencini C; Giampietro C; Bertoni M; Tumino E; Scatena F; Bresci G
J Crohns Colitis; 2013 Dec; 7(12):e692-7. PubMed ID: 23870727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
